Valley National Advisers’s Cellyan Biotechnology HKPD Stock Holding History

Valley National Advisers’s Portfolio HKPD Stock Details HKPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,000	Closed	-$16K	–	911
2025 Q2	$16K	Buy	+13,000	New	+$16.1K	﹤0.01%	499

Other funds holding HKPD

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Valley National Advisers's HKPD Position: Q3 2025 in Review

Valley National Advisers sold out of Cellyan Biotechnology (HKPD) in Q3 2025, closing a stake of 13,000 shares — an estimated $16K sold.

Valley National Advisers first reported a position in HKPD in Q2 2025 and held it in 1 quarter. The position peaked at $16K in Q2 2025. 2 funds tracked by Wall St. Rank hold HKPD as of Q3 2025.

Valley National Advisers reported no remaining Cellyan Biotechnology position as of Q3 2025 after selling out during the quarter.
Valley National Advisers sold 13,000 Cellyan Biotechnology shares in Q3 2025, an estimated $16K.
Valley National Advisers first reported a position in Cellyan Biotechnology in Q2 2025 and held it in 1 quarter.
Valley National Advisers's Cellyan Biotechnology position peaked at $16K in Q2 2025.
2 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q3 2025.

Based on Valley National Advisers's 13F filing for Q3 2025, filed 17 Oct 2025.